Table 1 APOE genotype and allele frequencies for 198 cases of frontotemporal lobar degeneration, overall and stratified by sex and necropsy confirmation, and 756 control cases, overall and stratified by sex.
Patient group | APOE genotype | Allele frequency | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
ε2/ε2 | ε2/ε3 | ε2/ε4 | ε3/ε3 | ε3/ε4 | ε4/ε4 | ε2 | ε3 | ε4 | ||
FTLD | ||||||||||
All patients (198) | 1 | 20 | 2 | 111 | 53 | 11 | 6.1 | 74.5 | 19.4 | |
Male (103) | 0 | 9 | 1 | 55 | 31 | 7 | 4.9 | 72.3 | 22.3 | |
Female (95) | 1 | 11 | 1 | 56 | 22 | 4 | 7.4 | 76.3 | 16.3 | |
Confirmed (50) | 1 | 4 | 0 | 30 | 13 | 2 | 6.0 | 77.0 | 17.0 | |
Unconfirmed (148) | 0 | 16 | 2 | 81 | 40 | 9 | 6.1 | 73.6 | 20.3 | |
Controls | ||||||||||
All (756) | 2 | 108 | 15 | 445 | 174 | 12 | 8.4 | 77.5 | 14.1 | |
Male (227) | 2 | 34 | 5 | 136 | 49 | 1 | 9.5 | 78.2 | 12.3 | |
Female (529) | 0 | 74 | 10 | 309 | 125 | 11 | 7.9 | 77.2 | 14.8 |
Numbers of cases are given in parentheses.
FTLD, frontotemporal lobar degeneration.